by HTLV | Aug 21, 2022 | Publications
Adv Rheumatol. 2022 Aug 9;62(1):31. doi: 10.1186/s42358-022-00259-y. ABSTRACT BACKGROUND: Joint pain in the absence or with little synovitis is observed in a large percentage of HTLV-1 infected subjects. As the virus infect CD4 + and CD8 + positive, macrophages and B...
by HTLV | Aug 21, 2022 | Publications
Front Immunol. 2022 Aug 1;13:959382. doi: 10.3389/fimmu.2022.959382. eCollection 2022. ABSTRACT Eukaryotic cells employ a broad range of mechanisms to regulate gene expression. Among others, mRNA alternative splicing is a key process. It consists of introns removal...
by HTLV | Aug 21, 2022 | Publications
Front Immunol. 2022 Jul 25;13:954077. doi: 10.3389/fimmu.2022.954077. eCollection 2022. ABSTRACT Human T-cell leukemia virus type 1 (HTLV-1) is the causative infectious agent of adult T-cell leukemia/lymphoma (ATL) and chronic neurological disease. The disparity...
by HTLV | Aug 21, 2022 | Publications
Front Immunol. 2022 Aug 1;13:939863. doi: 10.3389/fimmu.2022.939863. eCollection 2022. ABSTRACT Adult T-cell leukemia/lymphoma (ATL) is a T-cell lymphoproliferative neoplasm caused by the human T-cell leukemia virus type 1 (HTLV-1). Two viral proteins, Tax-1 and HBZ...
